Charles Theuer
Algemeen Directeur bij TRACON PHARMACEUTICALS, INC.
Vermogen: 803 641 $ op 30-04-2024
Actieve functies van Charles Theuer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-07-2006 | - |
| Algemeen Directeur | 02-08-2006 | - | |
| Investor Relations Contact | 01-07-2006 | - | |
| President | 02-08-2006 | - | |
| Comptroller/Controller/Auditor | 15-06-2018 | 18-09-2019 | |
| Financieel Directeur/CFO | 15-06-2018 | 29-01-2021 | |
| 4D MOLECULAR THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-01-2016 | - |
| Independent Dir/Board Member | 01-01-2016 | - | |
| ONCTERNAL THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-05-2018 | - |
| Independent Dir/Board Member | 01-05-2018 | - |
Loopbaan van Charles Theuer
Eerdere bekende functies van Charles Theuer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 | 01-01-2006 |
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2003 | 01-01-2004 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01-01-1991 | 01-01-1993 |
| University of California, Irvine | Corporate Officer/Principal | - | - |
Opleiding van Charles Theuer
| The University of California, San Francisco | Doctorate Degree |
| University of California, Irvine | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 10 |
Operationeel
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Beurs
- Insiders
- Charles Theuer
- Ervaring
